Ubs Asset Management Americas Inc Axogen, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 112,381 shares of AXGN stock, worth $2.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,381
Previous 41,510
170.73%
Holding current value
$2.04 Million
Previous $767,000
58.93%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding AXGN
# of Institutions
169Shares Held
40.2MCall Options Held
69.1KPut Options Held
0-
First Light Asset Management, LLC Edina, MN4.53MShares$82.3 Million7.55% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$49.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.51MShares$45.6 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.93MShares$35.1 Million0.03% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $768M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...